Comparison of the inhibitory potential of bavachalcone and corylin against UDP-glucuronosyltransferases

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Shan, Lina ^a   Yang, Shuman ^b   Zhang, Gang ^c   Zhou, Dun ^a   Qiu, Zhenyu ^a   Tian, Lei ^a   Yuan, Hongxia ^a   Feng, Yujun ^d   Shi, Xianbao ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d Maternity and Child Care Center of Qinhuangdao   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BAVACHALCONE; CORYLIN; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A10; GLUCURONOSYLTRANSFERASE 1A3; GLUCURONOSYLTRANSFERASE 1A7; GLUCURONOSYLTRANSFERASE 1A8; GLUCURONOSYLTRANSFERASE 2B4; HYMECROMONE; UNCLASSIFIED DRUG;

ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; CULLEN CORYLIFOLIUM; DRUG EFFECT; ENZYME INHIBITION; GLUCURONIDATION; HERB DRUG INTERACTION; HUMAN; IN VIVO STUDY; INFORMATION PROCESSING; KINETICS;

EID: 84900021729     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/958937     Document Type: Article

References (31)

1. Wang Y. F., Wu B., Yang J., Hu L.-M., Su Y.-F., Gao X.-M., A rapid method for the analysis of ten compounds in Psoralea corylifolia L. by UPLC. Chromatographia 2009 70 1-2 199 204 2-s2.0-70349664069 10.1365/s10337-009-1118-8
2. Qiao C. F., Han Q. B., Song J. Z., Mo S.-F., Kong L.-D., Kung H.-F., Xu H.-X., Chemical fingerprint and quantitative analysis of fructus psoraleae by high-performance liquid chromatography. Journal of Separation Science 2007 30 6 813 818 2-s2.0-34248365174 10.1002/jssc.200600339
3. Shinde A. N., Malpathak N., Fulzele D. P., Determination of isoflavone content and antioxidant activity in Psoralea corylifolia L. callus cultures. Food Chemistry 2010 118 1 128 132 2-s2.0-68349106934 10.1016/j.foodchem.2009.04. 093
4. Zaidi S. F. H., Yamada K., Kadowaki M., Usmanghani K., Sugiyama T., Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against helicobacter pylori. Journal of Ethnopharmacology 2009 121 2 286 291 2-s2.0-57949102984 10.1016/j.jep.2008.11. 001
5. Latha P. G., Evans D. A., Panikkar K. R., Jayavardhanan K. K., Immunomodulatory and antitumour properties of Psoralea corylifolia seeds. Fitoterapia 2000 71 3 223 231 2-s2.0-0034213131 10.1016/S0367-326X(99)00151-3
6. Liu F., Sun G. Q., Gao H. Y., Angelicin regulates LPS-induced inflammation via inhibiting MAPK/NF- B pathways. The Journal of Surgical Research 2013 185 1 300 309
7. Ren Y. X., Qin Y. H., Zheng L. L., Dai X. D., Tao L., Chen Y.-F., Cui Y., Electron microscopical observation on rats with Pneumocystis carinii pneumonia treated with Brucea javanica and Fructus psoraleae. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2006 24 6 473 475 2-s2.0-58149232610
8. Chen Z., Jin K., Gao L., Lou G., Jin Y., Yu Y., Lou Y., Anti-tumor effects of bakuchiol, an analogue of resveratrol, on human lung adenocarcinoma A549 cell line. European Journal of Pharmacology 2010 643 2-3 170 179 2-s2.0-77955267481 10.1016/j.ejphar.2010.06.025
9. Whelan L. C., Ryan M. F., Ethanolic extracts of euphorbia and other ethnobotanical species as inhibitors of human tumour cell growth. Phytomedicine 2003 10 1 53 58 2-s2.0-0037285551 10.1078/094471103321648665
10. Sugamoto K., Matsusita Y.-I., Matsui K., Kurogi C., Matsui T., Synthesis and antibacterial activity of chalcones bearing prenyl or geranyl groups from angelica keiskei. Tetrahedron 2011 67 29 5346 5359 2-s2.0-79958770453 10.1016/j.tet.2011.04.104
11. Park C. K., Lee Y., Chang E.-J., Lee M. H., Yoon J. H., Ryu J.-H., Kim H.-H., Bavachalcone inhibits osteoclast differentiation through suppression of NFATc1 induction by RANKL. Biochemical Pharmacology 2008 75 11 2175 2182 2-s2.0-43049128125 10.1016/j.bcp.2008.03.007
12. Jiangning G., Xinchu W., Hou W., Qinghua L., Kaishun B., Antioxidants from a Chinese medicinal herb- Psoralea corylifolia L. Food Chemistry 2005 91 2 287 292 2-s2.0-10044226977 10.1016/j.foodchem.2004.04.029
13. Shim S. H., Kim Y. J., Lee J. Y., Aldose reductase inhibitory activity of the compounds from the seed of Psoralea corylifolia. Journal of the Korean Society for Applied Biological Chemistry 2009 52 5 568 572
14. Hermann R., Richter O. V., Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions. Journal of Medicinal Plant Research 2012 78 13 1458 1477
15. Xie Z., Chen S., Heterogeneous expression of human CYP and its application in early stage of new drug research and development. Zhejiang Da Xue Xue Bao Yi Xue Ban 2013 42 1 109 113
16. Zientek M., Youdim K., Simultaneous determination of multiple CYP inhibition constants using a cocktail-probe approach. Methods in Molecular Biology 2013 987 11 13
17. Tian X., Cheng Z. Y., Jin H., Gao J., Qiao H. L., Inhibitory effects of baicalin on the expression and activity of CYP3A induce the pharmacokinetic changes of midazolam in rats. Evidence-Based Complementary and Alternative Medicine 2013 2013 10 10.1155/2013/179643 179643
18. Kiang T. K. L., Ensom M. H. H., Chang T. K. H., UDP- glucuronosyltransferases and clinical drug-drug interactions. Pharmacology and Therapeutics 2005 106 1 97 132 2-s2.0-15244342411 10.1016/j.pharmthera.2004.10. 013
19. Liu Y., Ramírez J., House L., Ratain M. J., Comparison of the drug-drug interactions potential of erlotinib and gefitinib via inhibition of UDP-glucuronosyltransferases. Drug Metabolism and Disposition 2010 38 1 32 39 2-s2.0-73149090339 10.1124/dmd.109.029660
20. Cao Y. F., He R. R., Cao J., Drug-drug interactions potential of icariin and its intestinal metabolites via inhibition of intestinal UDP- glucuronosyltransferases. Evidence-Based Complementary and Alternative Medicine 2012 2012 8 10.1155/2012/395912 395912
21. Ji H. Y., Lee H., Lim S. R., Kim J. H., Lee H. S., Effect of efavirenz on UDP-glucuronosyltransferase 1A1, 1A4, 1A6, and 1A9 activities in human liver microsomes. Molecules 2012 17 1 851 860 2-s2.0-84856161178 10.3390/ molecules17010851
22. Ji H. Y., Liu K. H., Lee H., Im S. R., Shim H. J., Son M., Lee H. S., Corydaline inhibits multiple cytochrome P450 and UDP- glucuronosyltransferase enzyme activities in human liver microsomes. Molecules 2011 16 8 6591 6602 2-s2.0-80052230944 10.3390/molecules16086591
23. Huang Y. P., Cao Y. F., Fang Z. Z., Glycyrrhetinic acid exhibits strong inhibitory effects towards UDP-glucuronosyltransferase(UGT) 1A3 and 2B7. Phytotherapy Research 2013 27 9 1358 1361
24. Cong M., Hu C. M., Cao Y. F., Cryptotanshinone and dihydrotanshinone I exhibit strong inhibition towards human liver microsome (HLM)-catalyzed propofol glucuronidation. Fitoterapia 2013 85 109 113
25. Šiller M., Anzenbacher P., Anzenbacherov E., Doleal K., Strnad M., In vitro interaction of a novel neutrophil growth factor with human liver microsomal cytochromes P450 and the contribution of UDP-glucuronosyltransferases to its metabolism. Xenobiotica 2011 41 11 934 944 2-s2.0-80053947166 10.3109/00498254.2011.593209
26. Zhuang X. M., Zhong Y. H., Xiao W. B., Identification and characterization of psoralen and isopsoralen as potent CYP1A2 reversible and time-dependent inhibitors in human and rat preclinical studies. Drug Metabolism and Disposition 2013 41 11 1914 1922
27. Li A. F., Shen G. L., Jiao S. Y., Metabolic detoxification of bakuchiol is mediated by cytochrome P450 enzymes in human liver microsomes. Beijing Da Xue Xue Bao 2012 44 3 431 436
28. Williams J. A., Hyland R., Jones B. C., Smith D. A., Hurst S., Goosen T. C., Peterkin V., Koup J. R., Ball S. E., Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUC 1/AUC) ratios. Drug Metabolism and Disposition 2004 32 11 1201 1208 2-s2.0-6944221357 10.1124/dmd.104.000794
29. Gil J., Ssiadek M. M., Gilbert syndrome: the UGT1A128 promoter polymorphism as a biomarker of multifactorial diseases and drug metabolism. Biomarkers in Medicine 2012 6 2 223 230 2-s2.0-84859067335 10.2217/bmm.12.4
30. Valenzuela J. B., González S. M., Escudero O. V., Influence of genetic polymorphisms in UGT1A1, UGT1A7 and UGT1A9 on the pharmacokynetics of irinotecan, SN-38 and SN-38G. Farmacia Hospitalaria 2013 37 2 111 127
31. Lu H., Fang Z. Z., Cao Y. F., Isoliquiritigenin showed strong inhibitory effect towards multiple UDP-glucuronosyltransferase(UGT) isoform-catalyzed 4-methylumbelliferone(4-MU) glucuronidation. Fitoterapia 2013 84 208 212